These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10100429)

  • 1. [Parkinsonian syndrome related to tacrine].
    Cabeza-Alvarez CI; González-Rubio M; García-Montero R; Alvarez-Tejerina A
    Neurologia; 1999 Feb; 14(2):96. PubMed ID: 10100429
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
    McSwain ML; Forman LM
    J Clin Psychopharmacol; 1995 Aug; 15(4):284. PubMed ID: 7593712
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse interaction of tacrine and haloperidol.
    Maany I
    Am J Psychiatry; 1996 Nov; 153(11):1504. PubMed ID: 8890692
    [No Abstract]   [Full Text] [Related]  

  • 4. [Detection of the cholinesterase inhibitor tacrine and its main metabolites].
    Schütz H; Ahrens B; Erdmann F; Weiler G
    Arch Kriminol; 2001; 207(5-6):154-61. PubMed ID: 11508052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of patients with Alzheimer's disease under treatment with tacrine].
    García-López MT; Guardado-Santervás P
    Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762
    [No Abstract]   [Full Text] [Related]  

  • 6. Late-onset alanine aminotransferase increase with tacrine.
    Terrell PS; Bredenkamp VL; JE Lammers
    Ann Pharmacother; 1996 Mar; 30(3):301. PubMed ID: 8833574
    [No Abstract]   [Full Text] [Related]  

  • 7. Involuntary weight loss associated with cholinesterase inhibitors in dementia.
    Stewart JT; Gorelik AR
    J Am Geriatr Soc; 2006 Jun; 54(6):1013-4. PubMed ID: 16776808
    [No Abstract]   [Full Text] [Related]  

  • 8. [Flare-up of arterial hypertension during treatment with tacrine].
    Allain H; Maruelle L; Beneton C; Rouault G; Belliard S
    Presse Med; 1996 Oct; 25(30):1388-9. PubMed ID: 8958861
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia.
    Maidment ID; Fox C; Boustani M
    Acta Psychiatr Scand; 2005 Jun; 111(6):403-9. PubMed ID: 15877706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 11. Myoclonus induced by tacrine.
    Abilleira S; Viguera ML; Miquel F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):281. PubMed ID: 9489553
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating autism pharmacologically: also tacrine might improve symptomatology in some cases.
    Niederhofer H
    J Child Neurol; 2007 Aug; 22(8):1054; author reply 1054-5. PubMed ID: 17761662
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholinesterase inhibitors in dementia: yes, no, or maybe?
    Lemstra AW; Richard E; van Gool WA
    Age Ageing; 2007 Nov; 36(6):625-7. PubMed ID: 17881419
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
    Liepelt I; Maetzler W; Blaicher HP; Gasser T; Berg D
    Dement Geriatr Cogn Disord; 2007; 23(6):351-67. PubMed ID: 17389795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rivastigmine against dementia in Parkinson disease?].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2973; author reply 2973-4. PubMed ID: 18026256
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study.
    Gutzmann H; Kühl KP; Hadler D; Rapp MA
    Pharmacopsychiatry; 2002 Jan; 35(1):12-8. PubMed ID: 11819153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation syndrome following donepezil cessation.
    Singh S; Dudley C
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):282-4. PubMed ID: 12673601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient elevations in pancreatic enzymes in response to a cholinesterase inhibitor.
    Pomara N; Citrome L
    Clin Neuropharmacol; 1995 Oct; 18(5):464-5. PubMed ID: 8665561
    [No Abstract]   [Full Text] [Related]  

  • 19. Transdermal iontophoresis of tacrine in vivo.
    Kankkunen T; Sulkava R; Vuorio M; Kontturi K; Hirvonen J
    Pharm Res; 2002 May; 19(5):704-7. PubMed ID: 12069176
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical predictors of response to Acetyl Cholinesterase Inhibitors: experience from routine clinical use in Newcastle.
    Pakrasi S; Mukaetova-Ladinska EB; McKeith IG; O'Brien JT
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):879-86. PubMed ID: 14533120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.